The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah(University of British Columbia), Andrew Roth(University of British Columbia), Rodrigo Goya(Canada's Michael Smith Genome Sciences Centre), Arusha Oloumi(University of British Columbia), Gavin Ha(University of British Columbia), Yongjun Zhao(Canada's Michael Smith Genome Sciences Centre), Gulisa Turashvili(University of British Columbia), Jiarui Ding(University of British Columbia), Kane Tse(Canada's Michael Smith Genome Sciences Centre), Gholamreza Haffari(University of British Columbia), Ali Bashashati(University of British Columbia), Leah Prentice(University of British Columbia), Jaswinder Khattra(University of British Columbia), Angela Burleigh(University of British Columbia), Damian Yap(University of British Columbia), Virginie Bernard(Pacific Centre for Reproductive Medicine), Andrew McPherson(University of British Columbia), Karey Shumansky(University of British Columbia), Anamaria Crisan(University of British Columbia), Ryan Giuliany(University of British Columbia), Alireza Heravi‐Moussavi(University of British Columbia), Jamie Rosner(University of British Columbia), Daniel Lai(University of British Columbia), İnanç Birol(Canada's Michael Smith Genome Sciences Centre), Richard Varhol(Canada's Michael Smith Genome Sciences Centre), Angela Tam(Canada's Michael Smith Genome Sciences Centre), Noreen Dhalla(Canada's Michael Smith Genome Sciences Centre), Thomas Zeng(Canada's Michael Smith Genome Sciences Centre), Kevin Ma(Canada's Michael Smith Genome Sciences Centre), Simon K. Chan(Canada's Michael Smith Genome Sciences Centre), Malachi Griffith(Canada's Michael Smith Genome Sciences Centre), Annie Moradian(Canada's Michael Smith Genome Sciences Centre), Siwei Cheng(Canada's Michael Smith Genome Sciences Centre), Gregg B. Morin(University of British Columbia), Peter H. Watson(University of British Columbia), Karen A. Gelmon(BC Cancer Agency), Stephen Chia(BC Cancer Agency), Suet‐Feung Chin(Cancer Research UK), Christina Curtis(University of Cambridge), Oscar M. Rueda(Cancer Research UK), Paul D.P. Pharoah(Cancer Research UK), Sambasivarao Damaraju(University of Alberta), John R. Mackey(University of Alberta), Kelly Hoon, Timothy T. Harkins, Vasisht Tadigotla, Mahvash Sigaroudinia(University of California, San Francisco), Philippe Gascard(University of California, San Francisco), Thea D. Tlsty(UCSF Helen Diller Family Comprehensive Cancer Center), J Costello(University of California, San Francisco), Irmtraud M. Meyer(University of British Columbia), Connie J. Eaves(BC Cancer Agency), Wyeth W. Wasserman(Pacific Centre for Reproductive Medicine), Steven J.M. Jones(Simon Fraser University), David G. Huntsman(BC Cancer Agency), Martin Hirst(Canada's Michael Smith Genome Sciences Centre), Carlos Caldas(Cancer Research UK), Marco A. Marra(Canada's Michael Smith Genome Sciences Centre), Samuel Aparício(University of British Columbia)
Cited by 2,021
Abstract
Related Papers
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Thérese Sørlie, Charles M. Perou, Robert Tibshirani et al.|Proceedings of the National Academy of Sciences|2001|10.9k
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker, Michael E. Mullins, Maggie C.U. Cheang et al.|Journal of Clinical Oncology|2009|4.9k